Fidelis Capital Partners’s Amgen AMGN Stock Holding History

Fidelis Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Buy	8,119 +762	+10%	+$261K	0.17%	105
2026 Q1	$2.59M	Sell	7,357 -906	-11%	-$323K	0.18%	103
2025 Q4	$2.7M	Buy	8,263 +708	+9%	+$225K	0.2%	95
2025 Q3	$2.13M	Buy	7,555 +2,904	+62%	+$842K	0.17%	104
2025 Q2	$1.32M	Buy	4,651 +28	+0.6%	+$7.93K	0.12%	138
2025 Q1	$1.3M	Buy	4,623 +14	+0.3%	+$4.13K	0.14%	121
2024 Q4	$1.33M	Buy	4,609 +160	+4%	+$47.5K	0.13%	131
2024 Q3	$1.4M	Buy	4,449 +90	+2%	+$29.4K	0.17%	113
2024 Q2	$1.36M	Buy	4,359 +465	+12%	+$137K	0.19%	90
2024 Q1	$1.11M	Buy	3,894 +325	+9%	+$95.1K	0.17%	113
2023 Q4	$1.03M	Buy	3,569 +753	+27%	+$205K	0.23%	90
2023 Q3	$757K	Buy	2,816 +391	+16%	+$97.6K	0.26%	89
2023 Q2	$538K	Buy	2,425 +157	+7%	+$36.4K	0.2%	121
2023 Q1	$536K	Buy	2,268 +1,513	+200%	+$371K	0.23%	111
2022 Q4	$204K	Buy	+755	New	+$202K	0.24%	110

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelis Capital Partners's AMGN Position: Q2 2026 in Review

Fidelis Capital Partners increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $261K and bringing the position to 8,119 shares worth $2.94M. The position accounts for 0.17% of the portfolio, ranked #105.

Fidelis Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Fidelis Capital Partners held 8,119 shares of Amgen worth $2.94M as of Q2 2026.
Fidelis Capital Partners bought 762 Amgen shares in Q2 2026, an estimated $261K.
Amgen made up 0.17% of Fidelis Capital Partners's portfolio in Q2 2026, its #105 holding.
Fidelis Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.